Eli Lilly and Company - Total Cash From Operating Activities

Eli Lilly and Company's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Total-Cash-From-Operating-Activities" stands at 16.06 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025, the highest value at least since 03/31/2012, the period currently displayed.

Eli Lilly and Company's third quarter result of 8.84 Billion USD for the item "Total Cash From Operating Activities" represents an increase of 186.24 percent compared to it's second quarter result.

Also, Eli Lilly and Company's third quarter result of 8.84 Billion USD for the item "Total Cash From Operating Activities" represents an increase of 138.04 percent compared to it's third quarter result of last year.

Looking again at the trailing twelve months series (TTM), Eli Lilly and Company's third quarter result of 16.06 Billion USD for the item "Total Cash From Operating Activities" represents an increase of 46.85 percent compared to it's second quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 166.27 percent compared to the value the year prior.
The 1 year change in percent is 166.27.
The 3 year change in percent is 98.80.
The 5 year change in percent is 141.61.
The 10 year change in percent is 384.08.

The Serie's long term average value is 5.95 Billion United States Dollars. It's latest available value, on 09/30/2025, is 170.10 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 03/31/2016, to it's latest available value, on 09/30/2025, is +508.76%.
The Serie's change in percent from it's maximum value, on 09/30/2025, to it's latest available value, on 09/30/2025, is 0.0%.